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Abstract
IMPORTANCE—Physicians in training are at high risk for depression. However, the estimated 
prevalence of this disorder varies substantially between studies.
OBJECTIVE—To provide a summary estimate of depression or depressive symptom prevalence 
among resident physicians.
DATA SOURCES AND STUDY SELECTION—Systematic search of EMBASE, ERIC, 
MEDLINE, and PsycINFO for studies with information on the prevalence of depression or 
depressive symptoms among resident physicians published between January 1963 and September 
2015. Studies were eligible for inclusion if they were published in the peer-reviewed literature and 
used a validated method to assess for depression or depressive symptoms.
DATA EXTRACTION AND SYNTHESIS—Information on study characteristics and depression 
or depressive symptom prevalence was extracted independently by 2 trained investigators. 
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Estimates were pooled using random-effects meta-analysis. Differences by study-level 
characteristics were estimated using meta-regression.
MAIN OUTCOMES AND MEASURES—Point or period prevalence of depression or 
depressive symptoms as assessed by structured interview or validated questionnaire.
RESULTS—Data were extracted from 31 cross-sectional studies (9447 individuals) and 23 
longitudinal studies (8113 individuals). Three studies used clinical interviews and 51 used self-
report instruments. The overall pooled prevalence of depression or depressive symptoms was 
28.8% (4969/17 560 individuals, 95% CI, 25.3%-32.5%), with high between-study heterogeneity 
(Q = 1247, τ2 = 0.39, I2 = 95.8%, P < .001). Prevalence estimates ranged from 20.9% for the 9-
item Patient Health Questionnaire with a cutoff of 10 or more (741/3577 individuals, 95% CI, 
17.5%-24.7%, Q = 14.4, τ2 = 0.04, I2 = 79.2%) to 43.2% for the 2-item PRIME-MD (1349/2891 
individuals, 95% CI, 37.6%-49.0%, Q = 45.6, τ2 = 0.09, I2 = 84.6%). There was an increased 
prevalence with increasing calendar year (slope = 0.5% increase per year, adjusted for assessment 
modality; 95% CI, 0.03%-0.9%, P = .04). In a secondary analysis of 7 longitudinal studies, the 
median absolute increase in depressive symptoms with the onset of residency training was 15.8% 
(range, 0.3%-26.3%; relative risk, 4.5). No statistically significant differences were observed 
between cross-sectional vs longitudinal studies, studies of only interns vs only upper-level 
residents, or studies of nonsurgical vs both nonsurgical and surgical residents.
CONCLUSIONS AND RELEVANCE—In this systematic review, the summary estimate of the 
prevalence of depression or depressive symptoms among resident physicians was 28.8%, ranging 
from 20.9% to 43.2% depending on the instrument used, and increased with calendar year. Further 
research is needed to identify effective strategies for preventing and treating depression among 
physicians in training.
Studies have suggested that resident physicians experience higher rates of depression than 
the general public.1-5 Beyond the effects of depression on individuals, resident depression 
has been linked to poor-quality patient care and increased medical errors.6-8 However, 
estimates of the prevalence of depression or depressive symptoms vary across studies, from 
3% to 60%.9,10 Studies also report conflicting findings about resident depression depending 
on specialty, postgraduate year, sex, and other characteristics.4,11-13 A reliable estimate of 
depression prevalence during medical training is important for informing efforts to prevent, 
treat, and identify causes of depression among residents.14 We conducted a systematic 
review and meta-analysis of published studies of depression or depressive symptoms in 
graduate medical trainees.
Methods
Search Strategy and Study Eligibility
Cross-sectional and longitudinal studies published between January 1963 and September 
2015 that reported on the prevalence of depression or depressive symptoms in interns, 
resident physicians, or both were identified using EMBASE, ERIC, MEDLINE, and 
PsycINFO (independently performed by D.A.M. and M.A.R.); by screening the reference 
lists of articles identified; and by correspondence with study investigators using the approach 
recommended by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
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(PRISMA) guidelines (Figure 1).15 The computer-based searches combined terms related to 
interns, resident physicians, and study design with those related to depression, without 
language restriction (full details of the search strategy are provided in eMethods 1 in the 
Supplement). Studies were included if they reported data on resident physicians, were 
published in peer-reviewed journals, and used a validated method to assess for depression or 
depressive symptoms.16
Data Extraction and Quality Assessment
The following information was independently extracted from each article by 2 trained 
investigators (D.A.M. and M.A.R.) using a standardized form: study design, geographic 
location, years of survey, specialty, postgraduate level, sample size, average age of 
participants, number and percentage of male participants, diagnostic or screening method 
used, outcome definition (ie, specific diagnostic criteria or screening instrument cutoff), and 
reported prevalence of depression or depressive symptoms. The most comprehensive 
publication was used when there were several involving the same population of residents. A 
modified version of the Newcastle-Ottawa Scale was used to assess the quality of 
nonrandomized studies included in systematic reviews and meta-analyses.17 This scale 
assesses quality in several domains: sample representativeness and size, comparability 
between respondents and nonrespondents, ascertainment of depressive symptoms, and 
statistical quality (full details regarding scoring are provided in eMethods 2 in the 
Supplement). Studies were judged to be at low risk of bias (≥3 points) or high risk of bias 
(<3 points). All discrepancies were resolved by discussion and adjudication of a third 
reviewer (S.S.).
Data Synthesis and Analysis
Prevalence estimates of depression or depressive symptoms were calculated by pooling the 
study-specific estimates using random-effects meta-analysis that accounted for between-
study heterogeneity.18 Binomial proportion confidence intervals for individual studies were 
calculated using the Clopper-Pearson method, which allows for asymmetry. When 
longitudinal studies reported prevalence estimates made at different time periods within the 
year, the overall period prevalence for the time period was used. Between-study 
heterogeneity was assessed by standard χ2 tests and the I2 statistic (ie, the percentage of 
variability in prevalence estimates due to heterogeneity rather than sampling error, or 
chance, with values ≥75% indicating considerable heterogeneity)19,20 and by comparing 
results from studies grouped according to prespecified study-level characteristics (study 
design, country, year of baseline survey, specialty, postgraduate level, Newcastle-Ottawa 
Scale components, age, sex, and diagnostic method) using stratified meta-analysis and meta-
regression.21,22 The influence of individual studies on the overall prevalence estimate was 
explored by serially excluding each study in a sensitivity analysis. A secondary analysis 
restricted to longitudinal studies reporting both preresidency and intraresidency depressive 
symptom prevalence estimates was performed to better isolate associations with the 
residency experience from associations with assessment tools. Bias secondary to small study 
effects was investigated by funnel plot and Egger test.23,24 All analyses were performed 
using R version 3.2.2 (R Foundation for Statistical Computing).25 Statistical tests were 2-
sided and used a significance threshold of P < .05.
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Results
Study Characteristics
Thirty-one cross-sectional10-13,26-52 and 23 longitudinal4,6-8,53-71 studies involving a total of 
17 560 individuals were included in the study (Figure 1, Table 1, and Table 2). Thirty-five 
took place in North America, 9 in Asia, 5 in Europe, 4 in South America, and 1 in Africa. 
Twenty-eight studies recruited residents from multiple specialties, while 26 recruited 
exclusively from single specialties. Thirteen studies included interns only, 36 included both 
interns and residents, and 5 included upper-level residents only. The median number of 
participants per study was 141 (range, 27-2323). Eleven studies assessed for depressive 
symptoms using the Beck Depression Inventory (BDI),72 11 used the Center for 
Epidemiologic Studies Depression Scale (CES-D),73 8 used the 2-item Primary Care 
Evaluation of Mental Disorders questionnaire (PRIME-MD),74 7 used the 9-item Patient 
Health Questionnaire (PHQ-9),75 4 used the Zung Self-rating Depression Scale (SDS),76 3 
used the Harvard Department of Psychiatry/National Depression Screening Day Scale 
(HANDS),77 and 7 used other methods.78-82 Three assessed for depression using structured 
interviews.83 The diagnostic criteria and scoring cutoffs used by the studies are summarized 
in Table 1. When evaluated by Newcastle-Ottawa quality assessment criteria, out of 5 
possible points, 3 studies received 5 points, 13 received 4 points, 23 received 3 points, 10 
received 2 points, 4 received 1 point, and 1 received 0 points (scores for individual studies 
are presented in eTable 1 in the Supplement).
Prevalence of Depression or Depressive Symptoms Among Resident Physicians
Meta-analytic pooling of the prevalence estimates of depression or depressive symptoms 
reported by the 54 studies yielded a summary prevalence of 28.8% (4969/17 560 individuals, 
95% CI, 25.3%-32.5%), with significant evidence of between-study heterogeneity (Q = 
1247, P < .001, τ2 = 0.39, I2 = 95.8%) (Figure 2). Sensitivity analysis, in which the meta-
analysis was serially repeated after exclusion of each study, demonstrated that no individual 
study affected the overall prevalence estimate by more than 1% (eTable 2 in the 
Supplement).
To provide a range of the depression or depressive symptom prevalence estimates identified 
by these methodologically diverse studies, estimates were stratified by screening instrument 
and cutoff score (Figure 3). Summary prevalence estimates ranged from 20.9% for the 
PHQ-9 with cutoff of 10 or more (741/3577 individuals, 95% CI, 17.5%-24.7%, Q = 14.4, 
τ2 = 0.04, I2 = 79.2%) to 43.2% for the 2-item PRIME-MD (1349/2891 individuals, 95% CI, 
37.6%-49.0%, Q = 45.6, τ2 = 0.09, I2 = 84.6%). The 8 studies using the 2-item PRIME-MD 
yielded significantly higher estimates than did the others (Q = 69.0, P < .001). In contrast, 
there were no significant differences between estimates made using the CES-D, PHQ-9, 
HANDS, BDI, or Zung SDS (Q = 8.65, P = .12), suggesting that variation between 
instruments did not explain the heterogeneity in the observed depression or depressive 
symptom prevalence estimates. A model including only those studies4,7,34,47,48,50,60,66 using 
inventories with specificities greater than 88% yielded a prevalence estimate of 20.2% 
(1119/5425, 95% CI, 18.0%-22.6%, Q = 22.0, P < .01, τ2 = 0.02, I2 = 68.2%).
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Prevalence of Depression or Depressive Symptoms by Study-Level Characteristics
Among all 54 studies, the prevalence of depression or depressive symptoms significantly 
increased with baseline survey year (slope = 0.5% per calendar-year increase; 95% CI, 
0.03%-0.9%; test of moderator, Q = 4.4, P = .04). This association persisted when studies 
using the 2-item PRIME-MD were excluded and the analysis was restricted to the 23 studies 
using the CES-D, PHQ-9, HANDS, BDI, or Zung SDS presented in Figure 3 (slope = 0.6% 
per calendar-year increase; 95% CI, 0.1%-1.2%, P = .02).
Among the full set of studies, no statistically significant differences in prevalence estimates 
were noted between cross-sectional vs longitudinal studies (2851/9447, 29.1% [95% CI, 
23.9% to 34.9%] vs 2111/8113, 28.4% [95% CI, 24.2% to 33.0%]; test for subgroup 
differences, Q = 0.04, P = .85), studies in the United States vs elsewhere (3026/10 883, 
26.6% [95% CI, 21.9% to 31.9%] vs 1936/6677, 31.1% [95% CI, 26.0% to 36.7%]; Q = 1.4, 
P = .23), studies of non-surgical vs both nonsurgical and surgical residents (1570/5841, 
28.9% [95% CI, 24.7% to 33.4%] vs 3392/11 719, 28.8% [95% CI, 23.6% to 34.7%]; Q = 0, 
P = .98), or studies of only interns vs those of only upper-level residents (1411/5127, 31.9% 
[95% CI, 25.4% to 39.1%] vs 211/1061, 26.6% [95% CI, 14.9% to 42.8%]; Q = 0.9, P = .62) 
(Figure 4). There were no significant associations between prevalence and mean or median 
age (slope = −1.0% per year [95% CI, −2.8% to 0.8%]; Q = 1.2, P = .28) or percentage of 
males (slope = 3.4% per percentage increase in males [95% CI, −28.9% to 22.1%]; Q = 0.1, 
P = .79).
When evaluated by Newcastle-Ottawa criteria, studies with lower total overall quality scores 
yielded higher depression estimates (660/1658, 36.7% [95% CI, 30.2%-43.7%] vs 4302/15 
902, 26.1% [95% CI, 22.4%-30.2%]; Q = 7.3, P = .007) (Figure 5). In terms of individual 
quality assessment criteria, higher prevalence estimates were found among studies with less 
representative participant populations (569/1472, 37.7% [95% CI, 32.4%-43.2%] vs 4393/16 
088, 26.8% [95% CI, 23.1%-30.9%]; Q = 10.4, P = .001) and less valid assessment methods 
(1835/4425, 36.2% [95% CI, 29.9%-43.0%] vs 3127/13 135, 25.7% [95% CI, 
22.6%-29.0%]; Q = 8.6, P = .003). No statistically significant differences in prevalence 
estimates were noted when studies were stratified by respondent/nonrespondent 
comparability criteria (Q = 0.11, P = .75) or by quality of descriptive statistic reporting (Q = 
0.23, P = .63).
Heterogeneity Within Screening Instruments
To identify potential sources of heterogeneity independent of assessment modality, 
heterogeneity was examined within the studies using common instruments when at least 5 
studies were available and at least 2 studies were in each comparator subgroup. Among the 7 
studies using the CES-D and a cutoff of 16 or greater, heterogeneity was not accounted for 
by study design (Q = 0.3, P = .61), baseline survey year (Q = 1.3, P = .25), specialty (Q = 
0.2, P = .70), sample size (Q = 2.1, P = .15), age (Q = 0.7, P = .41), or sex (Q = 0.7, P = .41) 
(full results are provided in eTable3 in the Supplement). Among the 8 studies using the 2-
item PRIME-MD, heterogeneity was partially explained by study design (cross-sectional 
studies yielded higher estimates, 49.8% vs 41.3%; Q = 5.2, P = .02) and respondent/
nonrespondent comparability (studies that established comparability yielded lower 
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estimates, 39.6% vs 50.4%; Q = 10.3, P = .001) but was not significantly explained by 
sample size (Q = 0.2, P = .64), sex (Q = 2.7, P = .10), baseline survey year (Q = 0.1, P = .
80), or Newcastle-Ottawa score (Q = 0.2, P = .64). Among 7 studies using the 21-item BDI 
with cutoff of 10 or greater, heterogeneity was in part explained by country (United States vs 
other, 10.7% vs 44.6%; Q = 30.7, P < .001), baseline survey year (Q = 13.4, P < .001), and 
sex (Q = 10.7, P = .001), but not by specialty (Q = 0.3, P = .58), postgraduate year (Q = 0, P 
= .99), age (Q = 1.3, P = .26), or respondent/nonrespondent comparability (Q = 0, P = .99).
Secondary Analysis of Longitudinal Studies
In a secondary analysis of 7 longitudinal studies,4,58,59,66-68,70 the temporal relationship 
between exposure to residency training and increased depressive symptoms was assessed 
(Table 3). Because studies used different assessment instruments, the relative change in 
depressive symptoms was calculated for each study individually (ie, follow-up divided by 
baseline prevalence), and then the relative changes derived from individual studies were 
meta-analyzed. Overall, the median absolute increase in depressive symptoms with the onset 
of residency training was 15.8% (range, 0.3%-26.3%; relative risk, 4.5).
Assessment of Publication Bias
Although visual inspection of the funnel plot revealed relatively minimal asymmetry 
(eFigure in the Supplement), there was evidence of small studies effect (Egger test P = .02), 
with smaller studies (<200 participants) reporting more extreme depression prevalence 
estimates than larger studies (32.0% [95% CI, 27.1%-37.4%] vs 24.5% [95% CI, 
20.0%-29.7%]; Q = 4.2, P = .04) (Figure 5).
Discussion
This systematic review and meta-analysis of 54 studies involving 17 560 physicians in 
training demonstrated that between 20.9% and 43.2% of trainees screened positive for 
depression or depressive symptoms during residency. Because the development of 
depression has been linked to a higher risk of future depressive episodes and greater long-
term morbidity, these findings may affect the long-term health of resident doctors.84,85 
Depression among residents may also affect patients, given established associations between 
physician depression and lower-quality care.6-8 These findings highlight an important issue 
in graduate medical education.
In interpreting the results of this meta-analysis, it is important to note that the vast majority 
of participants were assessed through self-report inventories that measured depressive 
symptoms, rather than gold-standard diagnostic clinical interviews for major depressive 
disorder. The sensitivity and specificity of these instruments for diagnosing major depressive 
disorder vary substantially (eTable 4 in the Supplement).86 Instruments such as the 2-item 
PRIME-MD have low specificity (66%, 95% CI, 48%-84%) and should be viewed as 
screening tools. In contrast, other commonly used instruments, such as the PHQ-9, have 
high sensitivity (88%, 95% CI, 74%-96%) and specificity (88%, 95% CI, 85%-90%) for 
diagnosing major depressive disorder and have been shown to be comparable with clinician-
administered assessments. Furthermore, although self-report measures of depressive 
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symptoms have limitations, there is evidence that among medical trainees the absence of 
anonymity in formal diagnostic assessments may compromise accurate assessment of 
sensitive personal information such as depressive symptoms.87 To reflect the heterogeneity 
of the measures included in this meta-analysis, a range of prevalence estimates (ie, 
20.9%-43.2%) was reported in addition to a single measure (ie, 28.8%).
This study found an increase in depressive symptoms among residents over time that in part 
explained the heterogeneity between studies. This increase, while modest, is notable given 
efforts by the Accreditation Council for Graduate Medical Education,88 European Working 
Time Directive,89 and others90 to limit trainee duty hours and improve work conditions. The 
identified trend may reflect the medical community's increased awareness of depression or 
developments external to medical education.91 Future studies should explore specific factors 
that may explain this trend.
A secondary analysis restricted to longitudinal studies found a significant increase in 
depressive symptoms among trainees after the start of residency. The median absolute 
increase in depressive symptoms among trainees was 15.8% (range, 0.3%-26.3%) within a 
year of beginning training. This finding, in combination with evidence that the prevalence of 
depressive symptoms is similar across specialties and countries, suggests that the underlying 
causes of depressive symptoms are common to the residency experience. Identifying the 
factors that negatively affect trainee mental health may help inform the development of 
effective interventions for the reduction of depression that would be generalizable to 
different countries and specialties.
Variation in study sample size contributed importantly to the observed heterogeneity in the 
data. Studies with fewer participants generally yielded more extreme prevalence estimates, 
suggesting the presence of publication bias. Furthermore, some studies used screening 
instruments in nonstandard ways (eg, with cutoff scores that have not been validated). These 
variations were captured in part by Newcastle-Ottawa score, which assessed the risk of bias 
in each study. Studies with higher risk of bias yielded higher prevalence estimates of 
depressive symptoms. Study design (ie, cross-sectional vs longitudinal), country, survey 
years, specialty, postgraduate level, age, and sex also contributed to the heterogeneity 
between studies.
Limitations should be considered when interpreting the findings of this study. First, a 
substantial amount of the heterogeneity among the studies remained unexplained by the 
variables examined. Unexamined factors, such as the institutional cultures of specific 
residency programs, may contribute to the risk for depressive symptoms among trainees. A 
better understanding of program culture and working environments may help elucidate some 
of the root causes of depressive symptoms. Second, the data were derived from studies that 
used different designs and involved different groups of trainees (eg, from different countries, 
specialties, and years of training). For example, all but 3 studies used screening tools to 
measure depressive symptoms, and the 3 that employed structured interviews used 
convenience samples not representative of the resident population at large. Because the 
studies were heterogeneous with respect to screening inventories and resident populations, 
the prevalence of major depressive disorder could not be precisely determined. However, a 
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secondary meta-analysis of studies using validated, high-specificity (>88%) inventories 
involving 5425 participants yielded a prevalence of 20.2%, which may better reflect the true 
prevalence of major depression. Third, the analysis relied on aggregated published data. A 
multicenter prospective study using a single validated measure of depression and structured 
diagnostic interviews in a random subset of participants would provide a more accurate 
estimate of the prevalence of depression among physicians in training.
Conclusions
In this systematic review, the summary estimate of the prevalence of depression or 
depressive symptoms among resident physicians was 28.8%, ranging from 20.9% to 43.2% 
depending on the instrument used, and increased with time. Further research is needed to 
identify effective strategies for preventing and treating depression among physicians in 
training.
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Figure 1. Flow Diagram for Identifying Studies on the Prevalence of Depression or Depressive 
Symptoms Among Resident Physicians
All studies identified by hand searching reference lists were found in the database search. 
For simplicity, this number is not duplicated in the diagram.
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Figure 2. Meta-analysis of the Prevalence of Depression or Depressive Symptoms Among 
Resident Physicians
Contributing studies are stratified by screening modality and ordered by increasing sample 
size. The area of each square is proportional to the inverse variance of the estimate. The 
dotted line marks the overall summary estimate for all studies, 28.8% (4969/17 560 
individuals, 95% CI, 25.3%-32.5%, Q = 1247.11, τ2 = 0.39, I2 = 95.8% [95% CI, 
95.0%-96.4%], P < .001). (Refer to footnotes of Table 1 and Table 2 for expanded names of 
diagnostic instruments.)
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Figure 3. Meta-analyses of the Prevalence of Depressive Symptoms Among Resident Physicians 
in Subsets of Studies Stratified by Screening Modality and Cutoff Score
The area of each diamond is proportional to the inverse variance of the estimate. BDI 
indicates Beck Depression Inventory; CES-D, Center for Epidemiologic Studies Depression 
Scale; HANDS, Harvard Department of Psychiatry/National Depression Screening Day 
Scale; PHQ-9, 9-item Patient Health Questionnaire; PRIME-MD, 2-item Primary Care 
Evaluation of Mental Disorders questionnaire; Zung SDS, Zung Self-rating Depression 
Scale.
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Figure 4. Meta-analyses of the Prevalence of Depression or Depressive Symptoms Among 
Resident Physicians Stratified by Study-Level Characteristics
The area of each diamond is proportional to the inverse variance of the estimate.
Mata et al. Page 16
JAMA. Author manuscript; available in PMC 2016 May 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. Meta-analyses of the Prevalence of Depression or Depressive Symptoms Among 
Resident Physicians Stratified by Newcastle-Ottawa Scale Components and by Total Score
The area of each diamond is proportional to the inverse variance of the estimate.
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